BioMarin Pharmaceutical Stock Price - BMRN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
BioMarin Pharmaceutical Inc BMRN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 67.73 0.00 0.00 0.00 67.73 08:38:27
Bid Price Ask Price Spread Spread % News
66.70 69.40 2.70 3.89% - -
Stock Trades Traded Volume Average Volume 52 Week Range
5 21 1,364,214 62.88 - 103.11
Last Trade Time Type Quantity Stock Price Currency
08:37:54 5 $ 67.46 USD

BioMarin Pharmaceutical Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 12.16B 179.46M $ -77.21M -0.44 -94.91 177.77M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 16.00 0.90%

more financials information »

BioMarin Pharmaceutical News

Date Time Source News Article
10/16/201916:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)
10/09/201908:31PR Newswire (US)BioMarin to Host Third Quarter 2019 Financial Results..
10/07/201908:31PR Newswire (US)BioMarin Promotes Lon Cardon, Ph.D. to Chief Scientific..
10/01/201908:30PR Newswire (US)BioMarin to Participate in Jefferies Gene Therapy/Editing..
9/26/201908:31PR Newswire (US)BioMarin, Pioneer in Phenylketonuria (PKU) Therapies,..
9/18/201918:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/09/201916:05PR Newswire (US)BioMarin to Participate in Morgan Stanley 17th Annual Global..

Latest BMRN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BMRN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week68.3570.2167.5168.291,325,745-0.62-0.91%
1 Month72.0872.7462.8867.121,429,090-4.35-6.03%
3 Months80.8281.7362.8871.971,256,876-13.09-16.2%
6 Months83.5891.9062.8878.401,260,432-15.85-18.96%
1 Year102.27103.1162.8884.191,125,314-34.54-33.77%
3 Years82.67106.7462.8887.991,194,282-14.94-18.07%
5 Years75.00151.7762.1293.541,276,683-7.27-9.69%

BioMarin Pharmaceutical Description

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials.
Your Recent History
NASDAQ
BMRN
BioMarin P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191023 13:24:01